Seher Anjum1, Peter R Williamson1. 1. Laboratory of Clinical Immunology and Microbiology (LCIM), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
Abstract
PURPOSE OF REVIEW: To perform an extensive review of recent literature and provide an update on the current epidemiology, clinical features and management of cryptococcal disease with a focus on the differences between patients depending on their immune status. RECENT FINDINGS: Emerging literature has highlighted the inflammatory pathophysiology and varied manifestations of cryptococcal infections in patients who are apparently healthy but paradoxically have a more critical clinical course compared to their immunosuppressed counterparts. SUMMARY: Non-HIV cryptococcal meningitis has greater mortality compared to that seen in HIV patients. Basic science experiments closely analyzing the underlying pathophysiological response to this infection have demonstrated the predominant role of T cell-mediated inflammatory injury in causing worse clinical outcomes. Further studies are needed to define the need for immunosuppressive agents in the treatment of this illness.
PURPOSE OF REVIEW: To perform an extensive review of recent literature and provide an update on the current epidemiology, clinical features and management of cryptococcal disease with a focus on the differences between patients depending on their immune status. RECENT FINDINGS: Emerging literature has highlighted the inflammatory pathophysiology and varied manifestations of cryptococcal infections in patients who are apparently healthy but paradoxically have a more critical clinical course compared to their immunosuppressed counterparts. SUMMARY: Non-HIV cryptococcal meningitis has greater mortality compared to that seen in HIV patients. Basic science experiments closely analyzing the underlying pathophysiological response to this infection have demonstrated the predominant role of T cell-mediated inflammatory injury in causing worse clinical outcomes. Further studies are needed to define the need for immunosuppressive agents in the treatment of this illness.
Authors: J E Bennett; W E Dismukes; R J Duma; G Medoff; M A Sande; H Gallis; J Leonard; B T Fields; M Bradshaw; H Haywood; Z A McGee; T R Cate; C G Cobbs; J F Warner; D W Alling Journal: N Engl J Med Date: 1979-07-19 Impact factor: 91.245
Authors: Rachael M Liesman; Angela P Strasburg; Angela K Heitman; Elitza S Theel; Robin Patel; Matthew J Binnicker Journal: J Clin Microbiol Date: 2018-03-26 Impact factor: 5.948
Authors: Kyung J Kwon-Chung; James A Fraser; Tamara L Doering; Zhou Wang; Guilhem Janbon; Alexander Idnurm; Yong-Sun Bahn Journal: Cold Spring Harb Perspect Med Date: 2014-07-01 Impact factor: 6.915
Authors: John Panepinto; Kazimierz Komperda; Susana Frases; Yoon-Dong Park; Julianne T Djordjevic; Arturo Casadevall; Peter R Williamson Journal: Mol Microbiol Date: 2008-02-05 Impact factor: 3.501
Authors: Estelle Pasquier; John Kunda; Pierre De Beaudrap; Angela Loyse; Elvis Temfack; Síle F Molloy; Thomas S Harrison; Olivier Lortholary Journal: Clin Infect Dis Date: 2018-03-19 Impact factor: 9.079
Authors: Katherine Traino; Joseph Snow; Lillian Ham; Angela Summers; Laura Segalà; Talia Shirazi; Nadia Biassou; Anil Panackal; Seher Anjum; Kieren A Marr; William C Kreisl; John E Bennett; Peter R Williamson Journal: Sci Rep Date: 2019-12-05 Impact factor: 4.379
Authors: Seher Anjum; Owen Dean; Peter Kosa; M Teresa Magone; Kelly A King; Edmond Fitzgibbon; H Jeff Kim; Chris Zalewski; Elizabeth Murphy; Bridgette Jeanne Billioux; Jennifer Chisholm; Carmen C Brewer; Chantal Krieger; Waleed Elsegeiny; Terri L Scott; Jing Wang; Sally Hunsberger; John E Bennett; Avindra Nath; Kieren A Marr; Bibiana Bielekova; David Wendler; Dima A Hammoud; Peter Williamson Journal: Clin Infect Dis Date: 2021-11-02 Impact factor: 9.079
Authors: Lorenza Romani; Peter Richard Williamson; Silvia Di Cesare; Gigliola Di Matteo; Maia De Luca; Rita Carsetti; Lorenzo Figà-Talamanca; Caterina Cancrini; Paolo Rossi; Andrea Finocchi Journal: Front Immunol Date: 2021-07-15 Impact factor: 7.561